trans-4-n-Butylcyclohexanecarboxylic acid, 99.0%, 500g

1-((2R,3R,4R)-4-((tert-butyldimethylsilyl)oxy)-3-fluoro-5,5-bis(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98%, 500mg

Oxetan-3-ol, 97.00%, 100g

Ethyl 6-bromo-8-chloro-4-hydroxy-quinoline-3-carboxylate, 95.0%, 100mg

5-Bromo-2-hydroxy-3-methylbenzonitrile, 95.0%, 5g

2-(2-(2-METHYLCYCLOHEXYLOXY)PHENYL)ETHANOL, 95.0%, 250mg

2-amino-1-(3-methyl-2-thienyl)ethanol, 95.0%, 250mg

1-(((tert-Butoxycarbonyl)amino)methyl)-cyclopentanecarboxylic acid, 95.0%, 5g

2-(3-(Hydroxymethyl)piperidin-1-yl)acetonitrile, 95%, 1g

N-Methyl-N-(thien-2-ylmethyl)amine, 97.0%, 1g

1,1'-Thiobis(naphthalen-2-ol), 98+%, 5g

N-(imidazo[1,2-a]pyridin-3-yl)benzamide, 95+%, 250mg

N-(4-(Aminomethyl)phenyl)acetamide hydrochloride, 95.0%, 250mg